AURINIA PHARMACEUTICALS INC
πΊπΈUnited States
- Country
- πΊπΈUnited States
- Ownership
- -
- Established
- 2012-01-01
- Employees
- -
- Market Cap
- -
Aurinia Early Urinary Protein Reduction Predicts Response
- First Posted Date
- 2016-10-31
- Last Posted Date
- 2021-03-19
- Lead Sponsor
- Aurinia Pharmaceuticals Inc.
- Target Recruit Count
- 10
- Registration Number
- NCT02949973
- Locations
- π²πΎ
AURION Site, Kuala Lumpur, Malaysia
AURA-LV: Aurinia Urinary Protein Reduction Active - Lupus With Voclosporin (AURA-LV)
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2014-05-19
- Last Posted Date
- 2021-05-18
- Lead Sponsor
- Aurinia Pharmaceuticals Inc.
- Target Recruit Count
- 265
- Registration Number
- NCT02141672
- Locations
- πΊπ¦
AURA-LV Site, Zaporizhzhya, Ukraine
π§π¬AURA-L Site, Plovdiv, Bulgaria
π±π°AUR-LV Site, Kandy, Sri Lanka
Safety and Efficacy Study of Voclosporin and Tacrolimus in Transplantation
- First Posted Date
- 2012-04-27
- Last Posted Date
- 2014-01-20
- Lead Sponsor
- Aurinia Pharmaceuticals Inc.
- Registration Number
- NCT01586845
Randomized, Placebo and Ciclosporin Controlled Study of ISA247 in Plaque Psoriasis Patients
- First Posted Date
- 2006-12-06
- Last Posted Date
- 2009-07-30
- Lead Sponsor
- Aurinia Pharmaceuticals Inc.
- Target Recruit Count
- 642
- Registration Number
- NCT00408187
- Locations
- π΅π±
Isotechnika Investigational Site, Zabrze, Poland
Study of ISA247 (Voclosporin) in De Novo Renal Transplantation
- First Posted Date
- 2005-12-28
- Last Posted Date
- 2013-02-12
- Lead Sponsor
- Aurinia Pharmaceuticals Inc.
- Target Recruit Count
- 334
- Registration Number
- NCT00270634
- Locations
- π¨π¦
Isotechnika Investigational Site, Saskatoon, Saskatchewan, Canada
A 36-Week Extension to Protocol ISA04-03
- First Posted Date
- 2005-11-28
- Last Posted Date
- 2008-09-29
- Lead Sponsor
- Aurinia Pharmaceuticals Inc.
- Target Recruit Count
- 309
- Registration Number
- NCT00258713
- Locations
- π¨π¦
Isotechnika Investigational Site, Sherbrooke, Quebec, Canada
Randomized Placebo-controlled Study of ISA247 in Plaque Psoriasis
- First Posted Date
- 2005-10-27
- Last Posted Date
- 2023-03-27
- Lead Sponsor
- Aurinia Pharmaceuticals Inc.
- Target Recruit Count
- 451
- Registration Number
- NCT00244842
- Locations
- π¨π¦
Isotechnika Investigational Site, Ste. Foy, Quebec, Canada
π¨π¦Isotechnika Investigational Site', Edmonton, Alberta, Canada
Β© Copyright 2024. All Rights Reserved by MedPath